the efficacy of infusions of clotting factor concentrate on emergency reversal of anticoagulation after intracerebral hemorrhage

the efficacy of infusions of clotting factor concentrate on emergency reversal of anticoagulation after intracerebral hemorrhage - clotting factor concentrate on emergency reversal of anticoagulation after intracerebral hemorrhage

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000009836

Enrollment

Registered

2013-01-25

Start date

2013-01-25

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

intracerebral hemorrhage

Interventions

clotting factor concentrate(IX factor)

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: intracerebral hemorrhage on anticoagulation within 24 hours after onset

Exclusion criteria

Exclusion criteria: INR<1.3 on admission

Design outcomes

Primary

Measure	Time frame
modified Rankin score at 3 months	—

Countries

Japan

Contacts

Public ContactJunichi Uemura

Kawasaki Medical School Stroke Medicine

uemuratrail@yahoo.co.jp086-462-1111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026